Scienture Holdings, Inc.
Scienture Holdings develops specialty pharmaceutical products across multiple therapeutic areas and indications to address unmet market needs.
DEF 14ASep 18Latest SEC filing, period to Sep 18
Aug 20Latest story
August 2026
Scienture Holdings develops specialty pharmaceutical products across multiple therapeutic areas and indications to address unmet market needs.